MEFIB-Index and MAST-Score in the assessment of hepatic decompensation in metabolic dysfunction-associated steatosis liver disease-Individual participant data meta-analyses.

Nabil Noureddin,Veeral Ajmera,Jaclyn Bergstrom,Richele Bettencourt,Daniel Q Huang,Harris Siddiqi,Abdul M Majzoub,Tarek Nayfeh,Nobuharu Tamaki,Namiki Izumi,Atsushi Nakajima,Ramzan Idilman,Mesut Gumussoy,Digdem Kuru Oz,Ayse Erden,Rohit Loomba

Alimentary pharmacology & therapeutics（2023）

引用 0|浏览18

暂无评分

摘要

A combination of MRI-based biomarker and blood tests, MEFIB-Index and MAST-Score can predict the risk of hepatic decompensation in patients with MASLD.

查看译文

关键词

steatosis liver disease—individual,hepatic decompensation,metabolic

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要